- Home
- EXPE vs TEVA Comparison
EXPE vs TEVA Comparison
Compare EXPE & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXPE
- TEVA
- Stock Information
- Founded
- EXPE 1996
- TEVA 1901
- Country
- EXPE United States
- TEVA Israel
- Employees
- EXPE N/A
- TEVA N/A
- Industry
- EXPE Transportation Services
- TEVA Biotechnology: Pharmaceutical Preparations
- Sector
- EXPE Consumer Discretionary
- TEVA Health Care
- Exchange
- EXPE Nasdaq
- TEVA Nasdaq
- Market Cap
- EXPE 19.3B
- TEVA 18.4B
- IPO Year
- EXPE 1999
- TEVA N/A
- Fundamental
- Price
- EXPE $168.99
- TEVA $18.08
- Analyst Decision
- EXPE Buy
- TEVA Strong Buy
- Analyst Count
- EXPE 27
- TEVA 6
- Target Price
- EXPE $190.20
- TEVA $24.33
- AVG Volume (30 Days)
- EXPE 2.0M
- TEVA 12.8M
- Earning Date
- EXPE 05-08-2025
- TEVA 05-07-2025
- Dividend Yield
- EXPE 0.24%
- TEVA N/A
- EPS Growth
- EXPE 68.55
- TEVA N/A
- EPS
- EXPE 8.95
- TEVA N/A
- Revenue
- EXPE $13,691,000,000.00
- TEVA $16,616,000,000.00
- Revenue This Year
- EXPE $7.20
- TEVA $6.30
- Revenue Next Year
- EXPE $6.87
- TEVA N/A
- P/E Ratio
- EXPE $18.88
- TEVA N/A
- Revenue Growth
- EXPE 6.64
- TEVA 3.82
- 52 Week Low
- EXPE $107.25
- TEVA $12.47
- 52 Week High
- EXPE $207.73
- TEVA $22.80
- Technical
- Relative Strength Index (RSI)
- EXPE 59.29
- TEVA 74.33
- Support Level
- EXPE $144.69
- TEVA $14.17
- Resistance Level
- EXPE $162.54
- TEVA $16.86
- Average True Range (ATR)
- EXPE 5.93
- TEVA 0.59
- MACD
- EXPE 2.22
- TEVA 0.44
- Stochastic Oscillator
- EXPE 86.41
- TEVA 95.91
About EXPE Expedia Group Inc.
Expedia is the world's second-largest online travel agency by bookings, offering services for lodging (80% of total 2024 sales), air tickets (3%), rental cars, cruises, in-destination, and other (10%), and advertising revenue (7%). Expedia operates a number of branded travel booking sites, but its three core online travel agency brands are Expedia, Hotels.com, and Vrbo. It also has a metasearch brand, Trivago. Transaction fees for online bookings account for the bulk of sales and profits.
About TEVA Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.